-
A design specification for Critical Illness Digital Twins to cure sepsis: responding to the National Academies of Sciences, Engineering and Medicine Report: Foundational Research Gaps and Future Directions for Digital Twins
Authors:
Gary An,
Chase Cockrell
Abstract:
On December 15, 2023, The National Academies of Sciences, Engineering and Medicine (NASEM) released a report entitled: Foundational Research Gaps and Future Directions for Digital Twins. The ostensible purpose of this report was to bring some structure to the burgeoning field of digital twins by providing a working definition and a series of research challenges that need to be addressed to allow t…
▽ More
On December 15, 2023, The National Academies of Sciences, Engineering and Medicine (NASEM) released a report entitled: Foundational Research Gaps and Future Directions for Digital Twins. The ostensible purpose of this report was to bring some structure to the burgeoning field of digital twins by providing a working definition and a series of research challenges that need to be addressed to allow this technology to fulfill its full potential. In the work presented herein we focus on five specific findings from the NASEM Report: 1) definition of a Digital Twin, 2) using fit-for-purpose guidance, 3) developing novel approaches to Verification, Validation and Uncertainty Quantification (VVUQ) of Digital Twins, 4) incorporating control as an explicit purpose for a Digital Twin and 5) using a Digital Twin to guide data collection and sensor development, and describe how these findings are addressed through the design specifications for a Critical Illness Digital Twin (CIDT) aimed at curing sepsis.
△ Less
Submitted 16 June, 2024; v1 submitted 8 May, 2024;
originally announced May 2024.
-
Artificial neural networks for disease trajectory prediction in the context of sepsis
Authors:
Dale Larie,
Gary An,
Chase Cockrell
Abstract:
The disease trajectory for clinical sepsis, in terms of temporal cytokine and phenotypic dynamics, can be interpreted as a random dynamical system. The ability to make accurate predictions about patient state from clinical measurements has eluded the biomedical community, primarily due to the paucity of relevant and high-resolution data. We have utilized two distinct neural network architectures,…
▽ More
The disease trajectory for clinical sepsis, in terms of temporal cytokine and phenotypic dynamics, can be interpreted as a random dynamical system. The ability to make accurate predictions about patient state from clinical measurements has eluded the biomedical community, primarily due to the paucity of relevant and high-resolution data. We have utilized two distinct neural network architectures, Long Short-Term Memory and Multi-Layer Perceptron, to take a time sequence of five measurements of eleven simulated serum cytokine concentrations as input and to return both the future cytokine trajectories as well as an aggregate metric representing the patient's state of health. The neural networks converged within 50 epochs for cytokine trajectory predictions and health-metric regressions, with the expected amount of error (due to stochasticity in the simulation). The mapping from a specific cytokine profile to a state-of-health is not unique, and increased levels of inflammation result in less accurate predictions. Due to the propagation of machine learning error combined with computational model stochasticity over time, the network should be re-grounded in reality daily as predictions can diverge from the true model trajectory as the system evolves towards a probabilistic basin of attraction. This work serves as a proof-of-concept for the use of artificial neural networks to predict disease progression in sepsis. This work is not intended to replace a trained clinician, rather the goal is to augment intuition with quantifiable statistical information to help them make the best decisions. We note that this relies on a valid computational model of the system in question as there does not exist sufficient data to inform a machine-learning trained, artificially intelligent, controller.
△ Less
Submitted 28 July, 2020;
originally announced July 2020.
-
Precision medicine as a control problem: Using simulation and deep reinforcement learning to discover adaptive, personalized multi-cytokine therapy for sepsis
Authors:
Brenden K. Petersen,
Jiachen Yang,
Will S. Grathwohl,
Chase Cockrell,
Claudio Santiago,
Gary An,
Daniel M. Faissol
Abstract:
Sepsis is a life-threatening condition affecting one million people per year in the US in which dysregulation of the body's own immune system causes damage to its tissues, resulting in a 28 - 50% mortality rate. Clinical trials for sepsis treatment over the last 20 years have failed to produce a single currently FDA approved drug treatment. In this study, we attempt to discover an effective cytoki…
▽ More
Sepsis is a life-threatening condition affecting one million people per year in the US in which dysregulation of the body's own immune system causes damage to its tissues, resulting in a 28 - 50% mortality rate. Clinical trials for sepsis treatment over the last 20 years have failed to produce a single currently FDA approved drug treatment. In this study, we attempt to discover an effective cytokine mediation treatment strategy for sepsis using a previously developed agent-based model that simulates the innate immune response to infection: the Innate Immune Response agent-based model (IIRABM). Previous attempts at reducing mortality with multi-cytokine mediation using the IIRABM have failed to reduce mortality across all patient parameterizations and motivated us to investigate whether adaptive, personalized multi-cytokine mediation can control the trajectory of sepsis and lower patient mortality. We used the IIRABM to compute a treatment policy in which systemic patient measurements are used in a feedback loop to inform future treatment. Using deep reinforcement learning, we identified a policy that achieves 0% mortality on the patient parameterization on which it was trained. More importantly, this policy also achieves 0.8% mortality over 500 randomly selected patient parameterizations with baseline mortalities ranging from 1 - 99% (with an average of 49%) spanning the entire clinically plausible parameter space of the IIRABM. These results suggest that adaptive, personalized multi-cytokine mediation therapy could be a promising approach for treating sepsis. We hope that this work motivates researchers to consider such an approach as part of future clinical trials. To the best of our knowledge, this work is the first to consider adaptive, personalized multi-cytokine mediation therapy for sepsis, and is the first to exploit deep reinforcement learning on a biological simulation.
△ Less
Submitted 8 February, 2018;
originally announced February 2018.
